Enanta Pharmaceuticals News

Enanta Pharmaceuticals | 8-K: Current report

Mar 13 04:04

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Vance Terry

Mar 9 06:32

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Russell Lesley

Mar 9 06:31

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Peterson Kristine

Mar 9 06:27

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hata Yujiro S

Mar 9 06:23

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FOLETTA MARK G

Mar 9 06:17

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CARTER BRUCE L A

Mar 9 06:16

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gardiner Nathaniel S.

Feb 28 07:37

Enanta Pharmaceuticals | SCHEDULE 13G: Others

Feb 28 02:16

Enanta Pharmaceuticals | UPLOAD: Others

Feb 27 03:26

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Luu Brendan

Feb 15 09:28

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kieffer Tara Lynn

Feb 15 09:23

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gardiner Nathaniel S.

Feb 15 09:23

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rottinghaus Scott T.

Feb 15 09:18

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Or Yat Sun

Feb 15 09:18

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MELLETT PAUL J

Feb 15 09:13

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Luly Jay R.

Feb 15 09:03

Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.80%),Steven Boyd(9.80%)

Feb 15 04:30

Enanta Pharmaceuticals | CORRESP: CORRESP

Feb 15 03:26

Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.52%)

Feb 14 07:00